Phase2 Trial of High Dose Intravenous Ascorbic Acid as an Adjunct to Salvage Chemotherapy in Relapsed/ Refractory Lymphoma, Patients With Clonal Cytopenia of Undetermined Significance, and Chronic Myelomonocytic Leukemia
This study is testing whether giving high doses of Vitamin C along with standard chemotherapy can help make treatment work better for certain types of lymphoma and blood disorders that have returned or not responded to previous therapies. The goal is to see if Vitamin C helps make cancer cells more sensitive to the chemotherapy drugs.
Adults aged 18 and older who have a confirmed diagnosis of lymphoma that has returned or not responded to previous treatments, and who meet specific health and scan requirements, may join. Participants must not be pregnant or breastfeeding and must use reliable birth control if able to become pregnant.
Participants will receive high-dose intravenous Vitamin C alongside chemotherapy medications, and will undergo routine medical tests such as scans, blood draws, and possibly bone marrow biopsies to monitor their health. They will also answer questions about their symptoms and overall well-being throughout the study.
The study is currently open and recruiting patients at medical centers in Mankato and Rochester, Minnesota, as well as Eau Claire, Wisconsin.
- 1Tests high-dose Vitamin C as a helper to standard chemotherapy.
- 2Designed for adults with lymphoma that has returned or is hard to treat.
- 3Currently recruiting patients at locations in Minnesota and Wisconsin.
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.